Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) closed at $15.21 on October 30, 2026, down 2.8% from the previous close, on volume of 237,931 shares (30-day average 45,304).
Data as of October 30, 2026.
No headlines found.
No press releases found.
No news found.
The Direxion Daily Pharmaceutical & Medical Bull 3X ETF seek daily investment results, before fees and expenses of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. To be eligible for inclusion in the Index, stocks must satisfy one of the following combined size and liquidity criteria: (1) have a float-adjusted market capitalization above $300 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the Index rebalancing reference date) above 50%; (2) have a float-adjusted market capitalization above $500 million with a float-adjusted liquidity ratio above 90%; or (3) have a float-adjusted market capitalization above $400 million with a float-adjusted liquidity ratio above 150%. The Index is rebalanced quarterly.
Direxion Daily Pharmaceutical & Medical Bull 3X ETF trades on the ARCA stock market under the symbol PILL.
As of October 30, 2026, PILL stock price declined to $15.21 with 237,931 million shares trading.
PILL has a beta of 2.43, meaning it tends to be more sensitive to market movements. PILL has a correlation of 0.22 to the broad based SPY ETF.
PILL has a market cap of $15.97 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, PILL traded as high as $24.15 and as low as $3.62.
PILL has outperformed the market in the last year with a price return of +83.5% while the SPY ETF gained +11.0%. However, in the short term, PILL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -22.0% vs +3.9% return in SPY. But in the last 2 weeks, PILL shares have fared better than the market returning +6.2% compared to SPY -2.1%.
PILL support price is $14.89 and resistance is $16.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PILL shares will trade within this expected range on the day.
